Schroder Investment Management Group Purchases 18,146 Shares of Envista Holdings Co. (NYSE:NVST)

Schroder Investment Management Group increased its position in Envista Holdings Co. (NYSE:NVSTFree Report) by 2.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 844,062 shares of the company’s stock after purchasing an additional 18,146 shares during the quarter. Schroder Investment Management Group owned approximately 0.49% of Envista worth $20,308,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in NVST. Retirement Systems of Alabama increased its stake in shares of Envista by 2.0% in the 4th quarter. Retirement Systems of Alabama now owns 504,572 shares of the company’s stock valued at $12,140,000 after acquiring an additional 10,120 shares during the last quarter. Alberta Investment Management Corp increased its stake in shares of Envista by 41.7% in the 4th quarter. Alberta Investment Management Corp now owns 294,417 shares of the company’s stock valued at $7,084,000 after acquiring an additional 86,700 shares during the last quarter. Foundry Partners LLC bought a new stake in shares of Envista in the 4th quarter valued at about $3,571,000. Raymond James & Associates increased its stake in shares of Envista by 820.6% in the 4th quarter. Raymond James & Associates now owns 408,218 shares of the company’s stock valued at $9,822,000 after acquiring an additional 363,875 shares during the last quarter. Finally, Norges Bank bought a new stake in shares of Envista in the 4th quarter valued at about $42,874,000.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. Needham & Company LLC reaffirmed a “hold” rating on shares of Envista in a research note on Monday, June 3rd. JPMorgan Chase & Co. lowered their target price on Envista from $29.00 to $23.00 and set an “overweight” rating for the company in a research note on Thursday, May 2nd. Leerink Partnrs reaffirmed an “underperform” rating on shares of Envista in a research note on Monday, February 26th. SVB Leerink began coverage on shares of Envista in a research note on Monday, February 26th. They issued an “underperform” rating and a $19.00 price target on the stock. Finally, Robert W. Baird cut their price target on shares of Envista from $22.00 to $19.00 and set a “neutral” rating on the stock in a research note on Thursday, May 2nd. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $25.86.

View Our Latest Report on NVST

Envista Stock Performance

Shares of Envista stock opened at $18.15 on Tuesday. Envista Holdings Co. has a 12-month low of $17.64 and a 12-month high of $36.14. The company has a current ratio of 2.27, a quick ratio of 1.93 and a debt-to-equity ratio of 0.34. The business’s 50 day moving average is $19.29 and its 200-day moving average is $21.68.

Envista (NYSE:NVSTGet Free Report) last announced its quarterly earnings data on Wednesday, May 1st. The company reported $0.26 EPS for the quarter, missing analysts’ consensus estimates of $0.31 by ($0.05). The firm had revenue of $623.60 million during the quarter, compared to the consensus estimate of $634.85 million. Envista had a negative net margin of 4.70% and a positive return on equity of 5.84%. The business’s revenue was down .6% on a year-over-year basis. During the same period last year, the business earned $0.38 EPS. On average, equities research analysts predict that Envista Holdings Co. will post 1.22 earnings per share for the current year.

Envista Company Profile

(Free Report)

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.

See Also

Institutional Ownership by Quarter for Envista (NYSE:NVST)

Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.